In the second quarter, revenues for IBO’s Laboratory Sales Index grew 1.2%, 3.2% excluding currency, to $5,729 million. Operating profit improved 1.4% to $1,153 million. Based on continuing operations, operating margin slipped 30 basis points to 17.6% of sales. For the two companies (Oxford Instruments, Tecan) that did not report earnings before this issue’s publication, […]
Despite market volatility and anemic economic data, the Dow Jones Industrial Average, S&P 500 and NASDAQ improved 1.0%, 1.3% and 0.2% in July, respectively. US equity markets came under pressure due to weak retail and employment figures, as well as mixed earnings reports. Slowing economic data from Japan and China, along with rising Spanish and […]
In January, when IBO issued its industry forecast for 2012 (see IBO 1/15/12), the industry had just finished two consecutive years of robust growth, which suggested it might be possible for such strong growth to continue. Although at the time we developed the forecast, we did not have the benefit of fourth quarter results for […]
With the updated financials from Oxford Instruments, HORIBA and Shimadzu, the IBO Laboratory Sales Index has been slightly revised from the numbers that appeared in IBO’s May 15 issue. First-quarter Index sales grew 1.9% organically to $5,752 million. Operating profit climbed 8.6% to $1,253 million, and operating margin was 18.5% of sales. For the fiscal […]
This month, the NSF released preliminary R&D spending numbers for the US federal government for fiscal year 2011 (FY11), ending September 30, 2011. The data suggest the substantial impact that the absence of American Recovery and Reinvestment Act of 2009 (ARRA) funding had on R&D spending in FY11 (see IBO 6/15/12) and general changes in […]
Higher investments in new product development and increased R&D personnel spending elevated R&D spending in 2011. Total R&D spending in US dollars for 18 major publicly held analytical and life science instrument and lab product companies grew 14.2% to $1.96 billion, compared with 12.1% growth for the same companies in 2010 (see table, page 6). […]
Company Announcements QIAGEN’s first-quarter sales rose 13% at constant exchange rates, including 7% growth from acquisitions and a 1% decline from currency. At constant exchange rates, sales in the Americas, Europe/Middle East/Africa and Asia-Pacific grew 15%, 12% and 14% to make up 47%, 34% and 18% of sales, respectively. Seven emerging countries accounted for 10% […]
First-quarter revenues for the IBO Lab Equipment/Consumables Index grew 3.0%, 2.5% organically, to $4,088 million. Sales growth was hampered by lower capital spending in the US and Europe, including weak government and academic markets. Adjusted operating profit improved 5.0% to $743 million. Operating margin for the Index added 100 basis points to 19.2% of sales, […]
Reinach, Switzerland 6/26/12—Measurement instrumentation firm Endress+Hauser has acquired SpectraSensors for an undisclosed amount. SpectraSensors develops, manufactures and distributes laser-based gas analytical instruments utilizing tunable diode lasers. Based in Texas, the company has annual sales of $30 million and employs 90 people. “With SpectraSensors we are expanding our range in the field of analytics to include […]
Washington, DC 6/28/12—In a filing with the SEC, Thermo Fisher Scientific disclosed that it is seeking to sell its laboratory workstations business, which is part of its Laboratory Products and Services segment, in order to exit noncore businesses. The workstations business had 2011 sales of $180 million and an operating loss of $6 million, which […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
